[
  {
    "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
    "bbox": [
      194,
      153,
      1000,
      166
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
    "bbox": [
      112,
      170,
      1000,
      182
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "1. Term:",
    "bbox": [
      179,
      120,
      241,
      132
    ],
    "label": 10,
    "category": "Non-Compete"
  },
  {
    "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
    "bbox": [
      194,
      153,
      1000,
      166
    ],
    "label": 10,
    "category": "Non-Compete"
  },
  {
    "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
    "bbox": [
      112,
      170,
      1000,
      182
    ],
    "label": 10,
    "category": "Non-Compete"
  },
  {
    "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
    "bbox": [
      111,
      185,
      1000,
      198
    ],
    "label": 10,
    "category": "Non-Compete"
  },
  {
    "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
    "bbox": [
      111,
      202,
      655,
      213
    ],
    "label": 10,
    "category": "Non-Compete"
  },
  {
    "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
    "bbox": [
      195,
      234,
      1000,
      245
    ],
    "label": 10,
    "category": "Non-Compete"
  },
  {
    "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
    "bbox": [
      110,
      248,
      1000,
      263
    ],
    "label": 10,
    "category": "Non-Compete"
  },
  {
    "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
    "bbox": [
      111,
      265,
      1000,
      278
    ],
    "label": 10,
    "category": "Non-Compete"
  },
  {
    "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
    "bbox": [
      111,
      282,
      1000,
      294
    ],
    "label": 10,
    "category": "Non-Compete"
  },
  {
    "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
    "bbox": [
      110,
      297,
      1000,
      310
    ],
    "label": 10,
    "category": "Non-Compete"
  },
  {
    "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
    "bbox": [
      112,
      314,
      1000,
      326
    ],
    "label": 10,
    "category": "Non-Compete"
  },
  {
    "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
    "bbox": [
      111,
      330,
      1000,
      342
    ],
    "label": 10,
    "category": "Non-Compete"
  },
  {
    "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
    "bbox": [
      110,
      345,
      1000,
      358
    ],
    "label": 10,
    "category": "Non-Compete"
  },
  {
    "text": "on July 22, 2019.",
    "bbox": [
      110,
      361,
      234,
      375
    ],
    "label": 10,
    "category": "Non-Compete"
  },
  {
    "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
    "bbox": [
      194,
      394,
      1000,
      406
    ],
    "label": 10,
    "category": "Non-Compete"
  },
  {
    "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
    "bbox": [
      111,
      409,
      1000,
      422
    ],
    "label": 10,
    "category": "Non-Compete"
  },
  {
    "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
    "bbox": [
      111,
      425,
      1000,
      438
    ],
    "label": 10,
    "category": "Non-Compete"
  },
  {
    "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
    "bbox": [
      111,
      441,
      1000,
      453
    ],
    "label": 10,
    "category": "Non-Compete"
  },
  {
    "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
    "bbox": [
      111,
      458,
      1000,
      470
    ],
    "label": 10,
    "category": "Non-Compete"
  },
  {
    "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
    "bbox": [
      111,
      474,
      1000,
      486
    ],
    "label": 10,
    "category": "Non-Compete"
  },
  {
    "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
    "bbox": [
      111,
      490,
      1000,
      501
    ],
    "label": 10,
    "category": "Non-Compete"
  },
  {
    "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
    "bbox": [
      110,
      505,
      1000,
      518
    ],
    "label": 10,
    "category": "Non-Compete"
  },
  {
    "text": "2. Engagement:",
    "bbox": [
      179,
      537,
      302,
      551
    ],
    "label": 10,
    "category": "Non-Compete"
  },
  {
    "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
    "bbox": [
      194,
      571,
      1000,
      583
    ],
    "label": 10,
    "category": "Non-Compete"
  },
  {
    "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
    "bbox": [
      112,
      587,
      1000,
      599
    ],
    "label": 10,
    "category": "Non-Compete"
  },
  {
    "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
    "bbox": [
      112,
      604,
      1000,
      614
    ],
    "label": 10,
    "category": "Non-Compete"
  },
  {
    "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
    "bbox": [
      110,
      618,
      1000,
      631
    ],
    "label": 10,
    "category": "Non-Compete"
  },
  {
    "text": "MusclePharm, its Products, and the Licensed Products.",
    "bbox": [
      112,
      635,
      525,
      645
    ],
    "label": 10,
    "category": "Non-Compete"
  },
  {
    "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
    "bbox": [
      133,
      1000,
      519,
      1000
    ],
    "label": 10,
    "category": "Non-Compete"
  },
  {
    "text": "1. Term:",
    "bbox": [
      179,
      120,
      241,
      132
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
    "bbox": [
      194,
      153,
      1000,
      166
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
    "bbox": [
      112,
      170,
      1000,
      182
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
    "bbox": [
      111,
      185,
      1000,
      198
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
    "bbox": [
      111,
      202,
      655,
      213
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
    "bbox": [
      195,
      234,
      1000,
      245
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
    "bbox": [
      110,
      248,
      1000,
      263
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
    "bbox": [
      111,
      265,
      1000,
      278
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
    "bbox": [
      111,
      282,
      1000,
      294
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
    "bbox": [
      110,
      297,
      1000,
      310
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
    "bbox": [
      112,
      314,
      1000,
      326
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
    "bbox": [
      111,
      330,
      1000,
      342
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
    "bbox": [
      110,
      345,
      1000,
      358
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "on July 22, 2019.",
    "bbox": [
      110,
      361,
      234,
      375
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
    "bbox": [
      194,
      394,
      1000,
      406
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
    "bbox": [
      111,
      409,
      1000,
      422
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
    "bbox": [
      111,
      425,
      1000,
      438
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
    "bbox": [
      111,
      441,
      1000,
      453
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
    "bbox": [
      111,
      458,
      1000,
      470
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
    "bbox": [
      111,
      474,
      1000,
      486
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
    "bbox": [
      111,
      490,
      1000,
      501
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
    "bbox": [
      110,
      505,
      1000,
      518
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "2. Engagement:",
    "bbox": [
      179,
      537,
      302,
      551
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
    "bbox": [
      194,
      571,
      1000,
      583
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
    "bbox": [
      112,
      587,
      1000,
      599
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
    "bbox": [
      112,
      604,
      1000,
      614
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
    "bbox": [
      110,
      618,
      1000,
      631
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "MusclePharm, its Products, and the Licensed Products.",
    "bbox": [
      112,
      635,
      525,
      645
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
    "bbox": [
      133,
      1000,
      519,
      1000
    ],
    "label": 19,
    "category": "Revenue/Profit Sharing"
  },
  {
    "text": "1. Term:",
    "bbox": [
      179,
      120,
      241,
      132
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
    "bbox": [
      194,
      153,
      1000,
      166
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
    "bbox": [
      112,
      170,
      1000,
      182
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
    "bbox": [
      111,
      185,
      1000,
      198
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
    "bbox": [
      111,
      202,
      655,
      213
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
    "bbox": [
      195,
      234,
      1000,
      245
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
    "bbox": [
      110,
      248,
      1000,
      263
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
    "bbox": [
      111,
      265,
      1000,
      278
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
    "bbox": [
      111,
      282,
      1000,
      294
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
    "bbox": [
      110,
      297,
      1000,
      310
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
    "bbox": [
      112,
      314,
      1000,
      326
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
    "bbox": [
      111,
      330,
      1000,
      342
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
    "bbox": [
      110,
      345,
      1000,
      358
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "on July 22, 2019.",
    "bbox": [
      110,
      361,
      234,
      375
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
    "bbox": [
      194,
      394,
      1000,
      406
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
    "bbox": [
      111,
      409,
      1000,
      422
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
    "bbox": [
      111,
      425,
      1000,
      438
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
    "bbox": [
      111,
      441,
      1000,
      453
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
    "bbox": [
      111,
      458,
      1000,
      470
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
    "bbox": [
      111,
      474,
      1000,
      486
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
    "bbox": [
      111,
      490,
      1000,
      501
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
    "bbox": [
      110,
      505,
      1000,
      518
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "2. Engagement:",
    "bbox": [
      179,
      537,
      302,
      551
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
    "bbox": [
      194,
      571,
      1000,
      583
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
    "bbox": [
      112,
      587,
      1000,
      599
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
    "bbox": [
      112,
      604,
      1000,
      614
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
    "bbox": [
      110,
      618,
      1000,
      631
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "MusclePharm, its Products, and the Licensed Products.",
    "bbox": [
      112,
      635,
      525,
      645
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
    "bbox": [
      133,
      1000,
      519,
      1000
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "1. Term:",
    "bbox": [
      179,
      120,
      241,
      132
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "(a) This Agreement shall have an Initial Term of three (3) years. The Term shall commence on July 23, 2013 and shall expire on July 22.",
    "bbox": [
      194,
      153,
      1000,
      166
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "2016, unless otherwise terminated earlier pursuant to Section 9 of this Agreement. The period from July 23, 2013 to July 22, 2014 shall be referred to",
    "bbox": [
      112,
      170,
      1000,
      182
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "as the \"First Contract Year\"'. The period from July 23, 2014 to July 22, 2015 shall be referred to as the \"Second Contract Year\". The period from July",
    "bbox": [
      111,
      185,
      1000,
      198
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "23, 2015 to July 22, 2016 shall be referred to as the \"Third Contract Year\"'.",
    "bbox": [
      111,
      202,
      655,
      213
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "(b) In the event that MusclePharm shall achieve Net Sales (as defined below) of $20 million (the \"First Renewal Threshold'') in the.",
    "bbox": [
      195,
      234,
      1000,
      245
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "aggregate during the Third Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the *First",
    "bbox": [
      110,
      248,
      1000,
      263
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "Additional Term') on the same terms and conditions for the Initial Term except that: (i) no additional Stock Compensation (as defined below) shall",
    "bbox": [
      111,
      265,
      1000,
      278
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "be issued in connection with the renewal Term, (ii) the Cash Compensation for the First Additional Term shall be as set forth in Section 7 and",
    "bbox": [
      111,
      282,
      1000,
      294
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "Exhibit \"C Section (2) attached hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the First",
    "bbox": [
      110,
      297,
      1000,
      310
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "Additional Term pursuant to Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 million during each",
    "bbox": [
      112,
      314,
      1000,
      326
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "Contract Year of the First Additional Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the First Additional Term,",
    "bbox": [
      111,
      330,
      1000,
      342
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "then the First Additional Term shall commence on July 23, 2016, and the Agreement shall expire and terminate automatically without further notice.",
    "bbox": [
      110,
      345,
      1000,
      358
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "on July 22, 2019.",
    "bbox": [
      110,
      361,
      234,
      375
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "(c) In the event that MusclePharm shall achieve Net Sales of $50 million (the \"Second Renewal Threshold\") in the aggregate during the",
    "bbox": [
      194,
      394,
      1000,
      406
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "sixth Contract Year, then this Agreement shall automatically be renewed for an additional term of three (3) years (the \"Second Additional Term') on",
    "bbox": [
      111,
      409,
      1000,
      422
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "the same terms and conditions for the initial Term except that: (i) no additional Stock Compensation (as defined below) shall be issued in connection",
    "bbox": [
      111,
      425,
      1000,
      438
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "with the renewal Term, (ii) the Cash Compensation for the renewal Term shall be as set forth in Section 7 and Exhibit \"C Section (3) attached",
    "bbox": [
      111,
      441,
      1000,
      453
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "hereto, (iii) Endorser shall only be obligated to make two (2) Appearances in each Contract Year during the Second Additional Term pursuant to",
    "bbox": [
      111,
      458,
      1000,
      470
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "Section 4(a)(ii) below and (iv) the marketing budget to promote the Licensed Products shall be $5.0 in each Contract Year of the Second Additional",
    "bbox": [
      111,
      474,
      1000,
      486
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "Term (subject to Section 12(b) of this Agreement). If this Agreement is renewed for the Second Additional Term, then the Second Additional Term.",
    "bbox": [
      111,
      490,
      1000,
      501
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "shall commence on July 23, 2019 and the Agreement shall expire and terminate automatically without further notice on July 22, 2022",
    "bbox": [
      110,
      505,
      1000,
      518
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "2. Engagement:",
    "bbox": [
      179,
      537,
      302,
      551
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "(a) MusclePharm hereby engages Endorser and Endorser promises and agrees to hold himself available to use, evaluate, advertise and",
    "bbox": [
      194,
      571,
      1000,
      583
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "promote certain MusclePharm Products, as may be reasonably requested by MusclePharm in accordance with the terms and conditions set forth",
    "bbox": [
      112,
      587,
      1000,
      599
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "herein on a world-wide basis. Endorser also agrees to the use on a world-wide basis (as specified pursuant to Section 6 below and subject to the",
    "bbox": [
      112,
      604,
      1000,
      614
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "terms and conditions of this Agreement), during the Term, of his Name and Appearance Rights to advertise and promote the business of.",
    "bbox": [
      110,
      618,
      1000,
      631
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "MusclePharm, its Products, and the Licensed Products.",
    "bbox": [
      112,
      635,
      525,
      645
    ],
    "label": 35,
    "category": "Cap On Liability"
  },
  {
    "text": "Source: MUSCLEPHARM CORP, 10-K/A, 2/8/2017",
    "bbox": [
      133,
      1000,
      519,
      1000
    ],
    "label": 35,
    "category": "Cap On Liability"
  }
]